Arabic Arabic English English French French German German
dark

Avalo Therapeutics Appoints Stephen Smolinski as Chief Commercial Officer

Avalo Therapeutics, Inc. announced the appointment of Stephen Smolinski as Chief Commercial Officer, effective January 3, 2022. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Nearly 48,000 boosters given yesterday; 14 community cases; 34 people in hospital; two in ICU

Next Post

Ketamine and psychological therapy helped severe alcoholics abstain for longer in trial

Related Posts
Total
0
Share